Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients by Nick E.J. West, Peter N. Ruygrok, Clemens M.C. Disco, Mark W.I. Webster, Wietze K. Lindeboom, William W. O’Neill, Nestor F. Mercado, and Patrick W. Serruys Circulation Volume 109(7):867-873 February 24, 2004 Copyright © American Heart Association, Inc. All rights reserved.

Figure 1. Cumulative frequency curves for percent DS (top) and vessel RD (bottom) comparing diabetic and nondiabetic patients at 6-month angiographic follow-up. Figure 1. Cumulative frequency curves for percent DS (top) and vessel RD (bottom) comparing diabetic and nondiabetic patients at 6-month angiographic follow-up. Nick E.J. West et al. Circulation. 2004;109:867-873 Copyright © American Heart Association, Inc. All rights reserved.

Figure 2. Reference charts constructed to predict 6-month in-stent restenosis rates for nondiabetic (top) and diabetic (bottom) patients. Figure 2. Reference charts constructed to predict 6-month in-stent restenosis rates for nondiabetic (top) and diabetic (bottom) patients. Nick E.J. West et al. Circulation. 2004;109:867-873 Copyright © American Heart Association, Inc. All rights reserved.

Figure 3. Subtraction graph derived from reference chart data, generating incremental increased predicted risk of in-stent restenosis caused by the effect of diabetes mellitus alone. Figure 3. Subtraction graph derived from reference chart data, generating incremental increased predicted risk of in-stent restenosis caused by the effect of diabetes mellitus alone. Nick E.J. West et al. Circulation. 2004;109:867-873 Copyright © American Heart Association, Inc. All rights reserved.